Concord Biotech: Board Meeting Outcome for Outcome Of Board Meeting Held Today November 11 2024 - Unaudited Financial Results For The Second Quarter And Half Year Ended September 30 2024

Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended from time to time we enclose herewith the Unaudited Standalone and Consolidated Financial Results of the Company for the Second quarter and half year ended September 30 2024 along with the Limited Review Report with Unmodified Opinion issued by M/s. BSR & Co. LLP the Statutory auditors.